|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.73 USD | -0.39% |
|
-0.20% | +20.82% |
| 12-02 | Truist Raises Price Target on Omega Healthcare Investors to $46 From $44, Keeps Hold Rating | MT |
| 11-18 | UBS Initiates Coverage on Omega Healthcare Investors With Buy Rating, $50 Price Target | MT |
| Capitalization | 13.51B 11.62B 10.88B 10.14B 18.74B 1,216B 20.38B 127B 49.15B 574B 50.72B 49.64B 2,100B | P/E ratio 2025 * |
24x | P/E ratio 2026 * | 23.6x |
|---|---|---|---|---|---|
| Enterprise value | 17.8B 15.3B 14.33B 13.36B 24.68B 1,602B 26.84B 168B 64.73B 757B 66.81B 65.38B 2,766B | EV / Sales 2025 * |
16.6x | EV / Sales 2026 * | 16.2x |
| Free-Float |
95.52% | Yield 2025 * |
5.86% | Yield 2026 * | 5.91% |
Last Transcript: Omega Healthcare Investors, Inc.
| 1 day | -0.39% | ||
| 1 week | -0.20% | ||
| Current month | -0.41% | ||
| 1 month | +6.40% | ||
| 3 months | +7.02% | ||
| 6 months | +22.24% | ||
| Current year | +20.82% |
| 1 week | 45.36 |  | 46.36 |
| 1 month | 41.53 | | 46.36 |
| Current year | 35.04 | | 46.36 |
| 1 year | 35.04 | | 46.36 |
| 3 years | 25.61 | | 46.36 |
| 5 years | 24.81 | | 46.36 |
| 10 years | 13.33 | | 46.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Pickett
CEO | Chief Executive Officer | 63 | 31/05/2001 |
Matthew Gourmand
PSD | President | 50 | 31/12/2024 |
| Director of Finance/CFO | 62 | 31/07/2001 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Plavin
BRD | Director/Board Member | 65 | 16/07/2000 |
Charles Pickett
BRD | Director/Board Member | 63 | 29/05/2002 |
Craig Callen
CHM | Chairman | 69 | 07/06/2017 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 13.29% | 303 M€ | -21.21% | - |
| 1.02% | 1 M€ | -.--% | - |
| 1.02% | 0 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.39% | -0.20% | +15.95% | +51.27% | 13.57B | |
| +0.22% | -0.94% | +52.94% | +187.44% | 140B | |
| +0.20% | +0.66% | +29.74% | +74.33% | 37.79B | |
| -0.93% | -6.59% | -20.09% | -34.99% | 11.94B | |
| +0.28% | -0.77% | +74.48% | - | 8.9B | |
| -0.16% | +0.69% | +28.14% | +86.36% | 8.43B | |
| -1.58% | -4.49% | -4.85% | -14.54% | 6.14B | |
| +1.21% | -0.31% | +4.61% | +47.51% | 4.75B | |
| -0.55% | -1.97% | +24.45% | +142.68% | 4.36B | |
| -0.80% | -1.52% | +3.74% | +37.66% | 3.77B | |
| Average | -0.27% | -1.43% | +20.91% | +64.19% | 23.96B | |
| Weighted average by Cap. | -0.08% | -1.06% | +39.74% | +134.14% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.07B 921M 863M 804M 1.48B 96.4B 1.62B 10.09B 3.9B 45.53B 4.02B 3.93B 166B | 1.12B 965M 904M 843M 1.56B 101B 1.69B 10.57B 4.08B 47.71B 4.21B 4.12B 174B |
| Net income | 571M 490M 459M 428M 791M 51.35B 860M 5.37B 2.07B 24.25B 2.14B 2.1B 88.67B | 589M 507M 475M 442M 817M 53.05B 889M 5.55B 2.14B 25.06B 2.21B 2.17B 91.62B |
| Net Debt | 4.28B 3.68B 3.45B 3.22B 5.94B 386B 6.46B 40.36B 15.58B 182B 16.08B 15.74B 666B | 4.73B 4.06B 3.81B 3.55B 6.55B 425B 7.13B 44.51B 17.19B 201B 17.74B 17.36B 734B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/25 | 45.73 $ | -0.39% | 1,520,378 |
| 04/12/25 | 45.91 $ | +0.50% | 1,297,213 |
| 03/12/25 | 45.68 $ | -0.74% | 1,397,960 |
| 02/12/25 | 46.02 $ | +0.44% | 1,782,961 |
| 01/12/25 | 45.82 $ | -0.22% | 1,810,769 |
Delayed Quote Nyse, December 05, 2025 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- OHI Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition